Share This Article:

Attention Points of Research and Education in TCMP across Taiwan Strait and Recommendations for Future Research and Development of TCM in China Mainland Especially Fujian and Taiwan

Abstract Full-Text HTML Download Download as PDF (Size:458KB) PP. 41-51
DOI: 10.4236/cm.2013.42008    4,822 Downloads   6,715 Views   Citations

ABSTRACT

Objective: China mainland and Taiwan are separated by the Taiwan Strait, but their land edges are close to each other, blood relationship is very compact, and the origin is profound, the communication of Traditional Chinese Medicine (TCM) between China mainland especially Fujian and Taiwan district is more and more frequent. From the actuality and situation of traditional Chinese medicine and pharmacy (TCMP), the objective of this study was to briefly expound the points to which attention should be attached urgently in education, research and development of TCM between China mainland especially between Fujian and Taiwan, and be provide with several resolving threads and recommenddations to aim directly at the attention points, and wish it can offer some assistance to the development and generalization of the cross-Strait TCMP. Methods: The China Statistical Yearbook of Chinese Medicine (1987-2010), the Yearbook of Public Health of Taiwan (2009), the full-text data base of China National Knowledge Infrastructure (CNKI) (1993-2009), provides information on research and education in TCMP acrossTaiwan Straitin the last 10 years. The methods of analysis and comparison are applied in this study to show the TCMP situation betweenTaiwanandChinamainland. Result: Due to the differences in history, district, policy and legislation, the TCMP’s industry and trade, education, research and exploitation, standard and so on, have lots of differences betweenTaiwanandChinamainland, and many barriers are produced in the communication and cooperation of cross-Strait TCM and pharmacy. Conclusion: China mainland especially Fujian and Taiwan have the fierce intention to carry out thorough investigation in many territories of TCMP. The prospects and development space of communication and cooperation of cross-Strait TCMP are quite broad.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

S. Xi, Y. Wang, Y. Chuang, L. Qian, X. Qian, P. Li and D. Lu, "Attention Points of Research and Education in TCMP across Taiwan Strait and Recommendations for Future Research and Development of TCM in China Mainland Especially Fujian and Taiwan," Chinese Medicine, Vol. 4 No. 2, 2013, pp. 41-51. doi: 10.4236/cm.2013.42008.

References

[1] [1] X. C. Li, “Correlation between Quality Standard of Traditional Chinese Medicine Injections and Medication Safety,” Chinese Journal of Pharmacoepidemiology, Vol. 21, No. 11, 2012, pp. 38-40.
[2] S. X. Wang, “The Scientization of Chinese Herbal Drugs and the New Drug Exploitation of Chinese Herbals Have Been Emphasized by Taiwan,” Hebei Journal of Traditional Chinese Medicine, Vol. 25, No. 2, 2003, p. 113.
[3] Z. B. Yu, “From the Forum of Traditional Chinese Medicine and Pharmacy across Taiwan Strait to View the Trade Prospect of Traditional Chinese Drugs between Taiwan and Mainland China,” Modern Chinese Medicine, Vol. 12, No. 7, 2010, pp. 42-43.
[4] Y. Huang, “The Progress and Tendency of Research of Traditional Chinese Medicine in Taiwan District,” World Journal of Integrated Traditional and Western Medicine, Vol. 4, No. 6, 2009, pp. 452-454.
[5] “Six Cooperating Protocols Forming Complementation to Push about the Development of Traditional Chinese Medicine and Pharmacy in Taiwan District and China Mainland,” http://www.chemdrug.com/databases/detail/3-13214.html 2010-07-08
[6] X. J. Gao, “10 Kinds of Chinese Crude Drugs Getting into Taiwan Will Be Put into Source Management and Needs to Provide the Inspection Unit Testimonial by China State Administration of Quality Supervision and Be Confirmed by Taiwan,” Journal of Traditional Chinese Medicine Management, Vol. 19, No. 9, 2011, p. 859.
[7] T. B. Shih, “Research of System Analysis of Tonifying Chinese Herbal Medicines and Their Prescriptions Used on Human Stem Cells,” Yearbook of Chinese Medicine and Pharmacy, Vol. 24, No. 1, 2006, pp. 29-51.
[8] W. C. Wun. “Research on Processing Technique of Rhizoma Pinelliae (2-1),” Yearbook of Chinese Medicine and Pharmacy, Vol. 24, No. 3, 2006, pp. 1-39.
[9] S. S. Liou, “To Establish the Processing Standard and Processing Factory Norm of Chinese Crude Drug and Decoction Pieces of Cortex Magnoliae Officinalis,” Yearbook of Chinese Medicine and Pharmacy, Vol. 25, No. 4, 2007, pp. 89-146.
[10] L. R. Xiao, “The History Origin and Modern Development of Traditional Chinese Medicine in Fujian and Taiwan,” Journal of Fujian University of Traditional Chinese Medicine, Vol. 16, No. 1, 2006, pp. 58-59.
[11] J. H. Guh, “Effect Research of Chinese Herbals’ Ingredients on Antagonizing Cancer and Neovascularization and the Identification the Origin of Active Components (3 2),” Yearbook of Chinese Medicine and Pharmacy, Vol. 24, No. 2, 2006, pp. 75-94.
[12] M. D. Lin, “Taiwan Establishes the High-End Platform of Development and Verification of Traditional Chinese Medicine,” China Medicine and Pharmacy, Vol. 1, No. 5, 2011, pp. 4-5.
[13] J. Z. Fu, “The New Change and Tendency of Traditional Chinese Medicine Education in Taiwan Recent Years,” Journal of Traditional Chinese Medicine Management, Vol. 17, No. 8, 2009, pp. 686-688.
[14] X. Y. Su, “Current Situation of Higher Education of traditional Chinese Drug in Taiwan,” Chinese Journal of Information on Traditional Chinese Medicine, Vol. 14, No. 9, 2007, pp. 107-108.
[15] S. L. Huang, X. Y. Chen and C. M. Yang, “Play Area Advantage, Promote the Exchange and Development of Cross-Strait Traditional Chinese Medicine,” Strait Pharmaceutical Journal, Vol. 20, No. 10, 2008, pp. 142-145.
[16] N. Liao, “To Analyze the Cooperation and Development of Cross-Strait Industry of Chinese Medicine,” Journal of Traditional Chinese Medicine Management, Vol. 19, No. 6, 2011, pp. 497-500.
[17] X. F. Lin and D. Y. Lin, “General Situation of Administration of Traditional Chinese Medicine in Taiwan Area in 2009,” Journal of Fujian University of Traditional Chinese Medicine, Vol. 21, No. 1, 2011, pp. 70-72.
[18] D. C. Tang, “Pre-Test on Education of under Graduate Course of Traditional Chinese Medicine in Taiwan,” Lishizhen Medicine and Materia Medica Research, Vol. 17, No. 10, 2006, pp. 2096-2097.
[19] J. J. Shen, Y. L. Zhang and W. Q. Xu, “Present Situation and Suggestions of the Education of Chinese Medicine in Taiwan,” Education of Chinese Medicine, Vol. 21, No. 1, 2002, pp. 41-43.
[20] W. H. Bao, X. M. Liu, S. L. Ren and L. Li, “Compare the Setting Standards of TCM Hospitals in China Mainland with that in Taiwan District,” World Chinese Medicine, Vol. 5, No. 6, 2010, pp. 436-439.
[21] Department of Planning and Finance of State Administration of Traditional Chinese Medicine, “China Statistical Yearbook of Chinese Medicine (1987-2010),” http://www.satcm.gov.cn/1987-2010/start.htm
[22] Department of Health, the Executive Yuan of Taiwan, “The Statistical Annual Report of Medical Institutions Status and Hospital’s Utilization,” Yearbook of Public Health of Taiwan, 2009, p. 23.
[23] B. W. Cheng, “Overview of Education of Professional Talented Person of Traditional Chinese Drug in Taiwan,” Pharmaceutical Education, Vol. 11, No. 1, 1995, pp. 60-61.
[24] L. Liu, “Many Points of View on Westernizing of Traditional Chinese Medical Hospitals,” Hospital Management Forum, Vol. 22, No. 11, 2005, pp. 36-40.
[25] X. H. Xiao, L. Q. Huang and X. J. Ma, “Discussion on the New Connotation and Significance of Traditional Chinese Drug and Its Modernization,” China Journal of Chinese Materia Medica, Vol. 28, No. 3, 2003, pp. 282-286.
[26] L. Jin, “Current Situation of Research and Development of Traditional Chinese Drugs and Thinking about the Future Development,” China Medicine and Pharmacy, Vol. 1, No. 18, 2011, pp. 32-33.
[27] L. R. Xiao, “Characteristics, Research and Development of New Drugs of Traditional Chinese Medicine in Taiwan District for Recent Ten Years,” Journal of Fujian University of Traditional Chinese Medicine, Vol. 20, No. 2, 2010, pp. 64-65.
[28] G. Wang, J. Wang and W. Xu, “Study on the Extracting Condition of Antrodia Camphorata Polysaccharide,” Fujian Journal of Traditional Chinese Medicine, Vol. 42, No. 1, 2011, pp. 52-53.
[29] W. Xu, J. Wang and G. Wang, “Study on Toxicity Test for Antrodia Camphorata Capsule,” Strait Pharmaceutical Journal, Vol. 23, No. 5, 2011, pp. 41-43.
[30] L. H. Pan and W. Lu, “Analysis of Easy Confusion Species of Cross-Strait Traditional Chinese Drugs,” Journal of Fujian College of Traditional Chinese Medicine, Vol. 7, No. 1, 1997, pp. 33-34.
[31] D. Huang and L. L. Li, “Preliminary Discussion about Differences of TCM Quality Standards between Taiwan and Mainland China,” Chinese Pharmaceutical Affairs, Vol. 24, No. 11, 2010, pp. 1088-1090.
[32] D. S. Zhuang, P. Lin, Y. L. Zhang and L. Ye, “Strengthen the Technology Communication of Medical Science between Fujian and Taiwan to Promote the Development of Cross-Strait Health Service,” Fujian Medical Journal, Vol. 17, No. 3, 1995, pp. 102-103.
[33] N. Liao, “Play Area Advantage and Carry forward Traditional Culture: Fujian University of Traditional Chinese Medicine Paves the Way for the Bypass for the Exchange of Traditional Chinese Medicine between Fujian and Taiwan,” Relations across Taiwan Straits, Vol. 13, No. 3, 2009, pp. 52-53.
[34] M. Z. Lin, Z. B. Chen, “The Situation of Pharmaceutical Plant Resources in Southern Fujian,” Journal of Zhangzhou Normal University, Vol. 22, No. 4, 2009, pp. 99-103.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.